1 June 2024 updates as part of the Digital Transformation of Authority Required (Written) PBS listings
Page last updated: 1 June 2024
From 1 June 2024 the PBS listings for the medicine outlined in the table below will be updated as part of the Department of Health and Aged Care’s digital transformation of Authority Required (Written) Pharmaceutical Benefits Scheme (PBS) listings. Real time assessment of authority requests for these medicines will be available through Services Australia’s Online PBS Authorities (OPA) system, via Health Professional Online Services (HPOS).
For further information on these changes, please refer to the PBS news item published on 30 June 2022, ‘Digital Transformation of Authority Required (Written) PBS listings’.
The Department of Health and Aged Care is working to update all relevant PBS listings as quickly as possible. Further information will be published on the PBS website as groups of medicines are reviewed.
From 1 June 2024 the PBS listings for the following medicine will be updated
|
Medicine name, Form, Quantity |
PBS item code, Program code |
Indication, Treatment phase |
|---|---|---|
|
riociguat 500 microgram tablet, 42 |
11001B (HB) |
Chronic thromboembolic pulmonary hypertension – Initial treatment |
|
riociguat 500 microgram tablet, 42 |
11009K (HS) |
Chronic thromboembolic pulmonary hypertension – Initial treatment |
|
riociguat 1 milligram tablet, 42 |
10976Q (HB) |
Chronic thromboembolic pulmonary hypertension – Initial treatment |
|
riociguat 1 milligram tablet, 42 |
10990K (HS) |
Chronic thromboembolic pulmonary hypertension – Initial treatment |
|
riociguat 1.5 milligram tablet, 42 |
10989J (HB) |
Chronic thromboembolic pulmonary hypertension – Initial treatment |
|
riociguat 1.5 milligram tablet, 42 |
10794N (HS) |
Chronic thromboembolic pulmonary hypertension – Initial treatment |
|
riociguat 2 milligram tablet, 42 |
10984D (HB) |
Chronic thromboembolic pulmonary hypertension – Initial treatment |
|
riociguat 2 milligram tablet, 42 |
11012N (HS) |
Chronic thromboembolic pulmonary hypertension – Initial treatment |
|
riociguat 2.5 milligram tablet, 42 |
11002C (HB) |
Chronic thromboembolic pulmonary hypertension – Initial treatment |
|
riociguat 2.5 milligram tablet, 42 |
10985E (HS) |
Chronic thromboembolic pulmonary hypertension – Initial treatment |
